结果:热痛觉过敏在肿瘤细胞植入后的12 - 18天发生进展。
RESULTS: Thermal hyperalgesia developed between Days 12 and 18 after cancer cell inoculation.
背景:慢性痛包括痛觉过敏和痛觉感觉异常,是患者感到难以忍受和临床缺乏治疗手段的一种病理现象。
BACKGROUND: Chronic pain, including hyperalgesia and algesthesia paresthesia, is pathological phenomenons making the patients felt unendurable and lacking of clinical treatments.
因此,许多研究人员在寻求新的止痛药方时,都会把解除痛觉过敏及异位疼痛列入优先考量。
Many researchers, therefore, have amelioration of hyperalgesia and allodynia foremost in their minds as they hunt for new analgesics.
应用推荐